Scannell Timothy J
NovoCure Ltd · Director
Scannell Timothy J is listed in filings as Director at NovoCure Ltd. This profile follows SEC Form 4 activity through Jun 5, 2026, including sale activity. Recent filings connect the profile to NovoCure Ltd (NVCR), Insulet Corp (PODD), and Masimo Corp (MASI). The current snapshot covers public activity from Jun 11, 2024 to Jun 5, 2026. Reported amounts are shown as $274.5K to $279.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $17k999 shares | SellJun 3, 2025 | $17.32 | $15.84 | |
| $1M5k shares | SellSep 10, 2024 | $225.84 | $167.65 | |
| $1M7k shares | SellJun 10, 2024 | $190.51 | $167.65 |